AURO LABORATORIES
Back to Balance Sheet
|
AURO LABORATORIES Last 5 Year Total Non-Current Liabilities History
[Standalone]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Total Non-Current Liabilities | ₹46 Cr | ₹34 Cr | ₹20 Cr | ₹3.66 Cr | ₹3.31 Cr |
What is the latest Total Non-Current Liabilities ratio of AURO LABORATORIES ?
| Year | Total Non-Current Liabilities |
|---|---|
| Mar2026 | ₹46 Cr |
| Mar2025 | ₹34 Cr |
| Mar2024 | ₹20 Cr |
| Mar2023 | ₹3.66 Cr |
| Mar2022 | ₹3.31 Cr |
How is Total Non-Current Liabilities of AURO LABORATORIES Trending?
| Years | Total Non-Current Liabilities | % Change | |
|---|---|---|---|
| Mar2026 | ₹46 Cr | 33.91 | |
| Mar2025 | ₹34 Cr | 73.83 | |
| Mar2024 | ₹20 Cr | 441.63 | |
| Mar2023 | ₹3.66 Cr | 10.70 | |
| Mar2022 | ₹3.31 Cr | - | |
Compare Total Non-Current Liabilities of peers of AURO LABORATORIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| AURO LABORATORIES | ₹148.8 Cr | -0.7% | -5.4% | -15.2% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹473,509.0 Cr | 0.6% | 6% | 14.6% | Stock Analytics | |
| DIVIS LABORATORIES | ₹196,881.0 Cr | 1.2% | 10.5% | 7.7% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹190,832.0 Cr | -0.4% | 11% | 40.8% | Stock Analytics | |
| CIPLA | ₹113,894.0 Cr | -1.6% | -2.1% | -4.8% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹96,062.8 Cr | -4.6% | -14.8% | -8.4% | Stock Analytics | |
AURO LABORATORIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| AURO LABORATORIES | -0.7% |
-5.4% |
-15.2% |
| SENSEX | -1.1% |
-0.2% |
-6.6% |
You may also like the below Video Courses